CORNERSTONE THERAPEUTICS INC - COM (CRTX)

CUSIP: 21924P103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
4,436,390
Share change
+65,192
Total reported value
$42,097,717
Price per share
$9.49
Number of holders
61
Value change
+$618,243
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 21924P103?
CUSIP 21924P103 identifies CRTX - CORNERSTONE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CORNERSTONE THERAPEUTICS INC - COM (CRTX) as of Q4 2013

As of 31 Dec 2013, CORNERSTONE THERAPEUTICS INC - COM (CRTX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,436,390 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, GARDNER LEWIS ASSET MANAGEMENT L P, Ancora Advisors, LLC, Cheyne Capital Management (UK) LLP, BlackRock Fund Advisors, HAVENS ADVISORS LLC, State Street Corp, VANGUARD GROUP INC, and LONGFELLOW INVESTMENT MANAGEMENT CO LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.